Loading clinical trials...
Loading clinical trials...
An Open, Multicenter Phase II Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
Conditions
Interventions
SHR-A1811
SHR-1316
+1 more
Locations
2
China
Affiliated Cancer Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China
Start Date
February 26, 2025
Primary Completion Date
June 1, 2028
Completion Date
September 1, 2028
Last Updated
March 6, 2025
Lead Sponsor
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions